Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Sema4

Biotech & Life Sciences · Stamford, United States · Founded 2017 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$2.00B
Market cap · 2026
Revenue
$306M
Latest reported FY

Investors

8 investors on Sema4's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Global footprint

Where Sema4 has talent and traffic

Web traffic by country
180 monthly visits
across markets
🇺🇸 United States111.1%
Top 1 markets shown

Patent intelligence

$32k patent portfolio · 4 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$32k
<0.01% of market cap · 1086.7× smaller than top peer Veracyte ($35M)
4 active patent families
Where Sema4 innovates PathologyBioinformaticsOncologyData miningCiliated cell
Below peer median on Legal, Market, Technology

Quality vs same-sector peers

Sema4 on the five Patsnap quality dimensions

Sema4 in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Sema4 concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Sema4 and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Sema4 on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.